The world is full of great engineers, but they’re often under-utilized and under-recognized.
We know this because of our own lab work, and our research and education.
Our lab has produced a few award-winning projects over the past decade, but we’re also passionate about creating new ones.
To that end, we recently launched a new platform called the World Biotechnologies Awards, an online platform that aims to identify the best and brightest in biology, engineering and related fields.
With more than 10,000 entries and a shortlist of nearly 20,000 names, we’ve identified the top 20 biosciences projects we think are important to the next generation of innovators.1.
The Biomimetics Prize, The University of Toronto2.
Nano-Bio Engineering, Harvard University3.
Life-Cycle Biomass, Oxford University4.
Bio-Dynamics and Bio-Physics, the University of Chicago5.
Bioengineering from Scratch, University of Wisconsin-Madison6.
Microbiome Engineering, University College London7.
The Future of Bioengineering, Harvard Business School8.
A Life-Course Approach to Bioengineering with BioEngineering, The Harvard Business Review9.
Biotechnology, Harvard-MIT Institute for Advanced Study10.
The Bio-Life Project, University at BuffaloThe biotechnology industry is the most significant economic engine in the world, and there are many factors that affect it, from the size of companies to their scale, and the types of companies they’re based in.
Biotechnology companies are generally headquartered in the United States, but international growth is also on the rise.
As a result, biotechnology companies have to be globally competitive, both on a global scale and domestically.
So, in order to remain competitive, the industry needs to diversify its business, including its global operations.
As part of this, many of the world’s leading biotechnology and biotechnology-related companies have launched new ventures, often to bring new and innovative technologies to the biotechnology market.
For example, BioGenetics, a biotechnology company based in the UK, recently launched an entirely new biotechnology venture called BioGen.
BioGen Genetics will be focused on creating life-cycle biotechnology products, which include enzymes, enzymes that can produce new protein products, and enzyme-based drugs.
BioGen is launching its new venture on July 11.
Its mission is to commercialize new life-cycler technologies, such as enzymes that convert proteins into new molecules, and enzymes that produce new proteins, to help biotechnology industries become more competitive globally.
For instance, the company hopes to develop new enzymes that will make the conversion of proteins into protein products faster, more efficiently, and more cheaply.
The BioGen project will help BioGen take advantage of the opportunity to increase its global reach and build a stronger, more international biotechnology ecosystem.
BioGEN has a global presence, with a staff of approximately 500 people, and it will operate at a small scale to help expand its international reach and become a leader in this emerging field.
BioGener has a strong pipeline of research and development projects, and BioGen is working closely with the company to bring this product to market.
BioGener is already in the process of creating an integrated pipeline of life-cycles for its products.
The company’s research is focused on developing new enzymes, and BiGen’s life- cycles are focused on improving the efficiency of protein production.
BiGener is a joint venture between BioGen and an Australian company called Thermogenix.
BioGens development work is based on Thermigenix’s expertise in life- cycle biosensors.
Thermogeneix is a life-generation company that makes biotechnology tools for use in the field of life sciences.
ThermogenIX is a Life-cycle Biotechnology CompanyBioGen and Thermagenix will develop a life cycle biosensor for the enzymes BioGen plans to develop.
Thermolgix is also working on life-cycling enzymes that could make life-changing proteins.
BioGe is a biopharmaceutical company that focuses on the development of enzymes that are designed to catalyze biological reactions.
BioGe is working with Thermenex to develop life-curing enzymes, such that they can convert proteins and RNA into new products that are more useful for the biological world.
BioGens enzymes are designed for use as part of life cycle biological processes, including converting protein products to proteins that are useful for biotechnology, or producing new proteins for use by the biopharma industry.
BioMentors is an innovative biotechnology startup based in New York City.
Its bioengineering research is conducted in a collaborative environment with the best labs in the country.
The goal of the company is to produce life-long life-forms for the medical and scientific industries.
BioMission is a New York-based company that is developing a novel life-stage biosensor to detect and predict the onset of disease in patients